Open AccessPalbociclib Added No Benefit to Breast Cancer Adjuvant Endocrine Therapy
Author(s) -
Peter M. Goodwin
Publication year - 2021
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000737672.66308.9f
Subject(s) - palbociclib , medicine , breast cancer , oncology , interim analysis , cancer , adjuvant therapy , interim , trastuzumab , adjuvant , gynecology , clinical trial , metastatic breast cancer , archaeology , history